SCHEMBL30306152

SCHEMBL30306152

COc1cc([N+](=O)[O-])ccc1N1CCCCC1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.64
ALDH1A1 P00352 12/20 0.62
SMN1; SMN2 Q16637 6/20 0.62
LMNA P02545 4/20 0.62
MAPT P10636 4/20 0.62
MAPK1 P28482 1/20 0.62
CYP1A2 P05177 3/20 0.56
CYP3A4 P08684 3/20 0.56
CYP2C19 P33261 3/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2D6 P10635 1/20 0.56
MCOLN3 Q8TDD5 1/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
HPGD P15428 1/20 0.56
ALDH1A3 P47895 1/20 0.55
HTT P42858 2/20 0.54
PAX8 Q06710 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175637 1.00 GAA (0.64) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL1928415 0.98 ALDH1A1 (0.64) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL28507271 0.88 ALDH1A1 (0.59) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL28531881 0.87 MAPT (0.61) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL2062270 0.87 ALDH1A1 (0.64) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL29556577 0.87 ALDH1A1 (0.64) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL31267415 0.86 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2LMNAMAPTMAPK1
SCHEMBL2062084 0.86 SLC6A5 (0.64) ALDH1A1SMN1; SMN2LMNAMAPTMAPK1
SCHEMBL15725834 0.86 ALDH1A1 (0.64) GAAALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL6606828 0.86 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2LMNAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115772113-A Preparation method of Gilitinib intermediate, gilitinib intermediate prepared by preparation method and application of Gilitinib intermediate 上海厚博生物科技有限公司 2023-03-10 CN disclosed